Apheresis Market
Apheresis Market By Technology (Centrifugation, Membrane Filtration), By Product (Devices, Disposables), By Application (Renal Diseases, Neurology), By End User (Hospitals, Blood Collection Centres) & By Region - Global Market Insights 2022-2032
Analysis of Apheresis Market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Apheresis Market Outlook (2022-2032)
The global apheresis market is slated to be valued at US$ 2,990 Million in 2022 and is forecast to reach US$ 8,960 Million by 2032, mounting at a CAGR of 11.6% from 2022 to 2032. From 2017-2021 a CAGR of 10.3% was registered for the apheresis market.
Apheresis is a procedure wherein blood is withdrawn from a donor’s body, extraction of one or more blood components such as platelets, plasma, and white blood cells, and transfusing of the remaining blood back into the donor during the procedure or at the end of it.
Various initiatives taken by the government and private companies for the development of advanced medical services and for the delivery of effective treatment have been envisaged to shape the future of apheresis market.
Some of the leading applications for the solutions and products within the global apheresis market include neurology, cancer, cardiovascular diseases, diabetes, renal diseases, hematology, autoimmune diseases, and fibrosis, among others.
The key regions covered in global apheresis market are North America, Middle East and Africa, Europe, Latin America, and Asia Pacific. Among these, North America region led the global apheresis market in 2022, owing to the rising demand for plasma, intended for the production of medicines derived from plasma as well as the presence of well-trenched healthcare and medical infrastructure in the region.
The global apheresis market is primarily driven by the increasing incidence of chronic diseases worldwide, rise in number of platelet donors, and spike in R&D investments made by biotech and pharmaceutical companies.
Attributes |
Details |
|---|---|
|
Apheresis Market Size 2021 |
US$ 2,680 Million |
|
Estimated Market Value (2022E) |
US$ 2,990 Million |
|
Forecasted Market Value (2032F) |
US$ 8,990 Million |
|
Global Market Growth Rate (2022-2032) |
11.6%CAGR |
|
North America Market Share (2022-2032) |
45.5% |
|
Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Revenue of Apheresis Market from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032
As per the apheresis market industry research by Fact.MR - market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Apheresis Market industry increased at around 11.6% CAGR, wherein, countries such as the U.S., China, Japan, South Korea, and the UK held a significant share in the global market.
The market for apheresis is expected to grow at an immense rate and show some great results in the upcoming years. The advancement in healthcare and other pharmaceuticals is expected to increase as a result of the increased demand for effective COVID-19 treatments.
The Apheresis Market reached a valuation of US$ 2,680 Million in 2021 and is expected to cross US$ 2,990 Million mark by the end of 2022. Top Procedure, plasmapheresis is expected to grow with a huge CAGR of 10.7% during the forecasted period of 2022 to 2032. From the top application type perspective, Neurology has shown a CAGR of 11.2 % in the historical data and is expected to grow at the rate of 10.9% in the next 10 years.
What’s Driving High Demand for Apheresis Market?
The growing prevalence of diseases boosts the market growth
The increasing number of diseases, a rise in the demand for blood components and their associated safety, technological advancements in the development of new apheresis techniques, and an increase in reimbursement policies and funding for apheresis procedures are expected to drive market growth.
The increasing prevalence of chronic and acute diseases, increasing demand for blood transfusions, and product launches are the major factor driving the growth of the global apheresis equipment market during the forecast period.
Also, the increasing incidence of blood-related disorders combined with technological advancements in devices is expected to boost the apheresis market. Furthermore, increased automation in apheresis machines have led to shorter treatment duration and facilitated related procedures, which is expected to propel the market growth along the forecast period.
Favorable Reimbursement Scenario in Developed Regions Supporting Steady Growth of Apheresis Market
The introduction of new therapy lines such as stem cell therapy, immunoglobulin therapy, and radiotherapy for control and prevention of chronic diseases is inadvertently bolstering the adoption of apheresis procedures, in turn boosting the growth of the global apheresis market.
Governments of North America and Europe are diverting investments towards encouraging the adoption of quality healthcare through various programs such as Medicare, Medicaid, employee insurance programs, and Veterans Health Administration, which alleviates high-cost concerns regarding apheresis procedures.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Understanding the Impact of Underlying Challenges Present in the Apheresis Market
A lack of skilled professionals may impede the growth of the market.
Despite the emergence of new revenue channels for the apheresis market, there are numerous challenges present in the landscape, which could inadvertently narrow growth prospects. A key barrier to growth is the lack of skilled professionals.
Recent times have witnessed an epochal scale of technological changes, which has revolutionized the healthcare industry, and, in turn, its operations. However, scarcity of expert operators leads to an increase in the acquisition cost of well-informed resources, which adds up to the already high cost of apheresis procedures.
Healthcare expenses in developed regions such as North America and Europe are offset through government initiatives and reimbursement programs. However, cost concerns in developing and underdeveloped regions could shrink opportunities for players in the apheresis market, though these present highly lucrative, yet largely untapped markets.
Comparative View of Apheresis Markets
Apheresis Market :
|
Attributes |
Apheresis Market |
|
Growth Factor |
Rising incidence of blood-related disorders is expected to boost demand by increasing the usage rates of apheresis machines and kit are anticipated to drive the apheresis market |
|
Opportunity |
The advancements in the medical technologies as well as the increasing popularity and population participation in blood donation drives and camps is expected to provide opportunities for the growth of the apheresis market |
Therapeutic Apheresis Market :
|
Attributes |
Therapeutic Apheresis Market |
|
Growth Factor |
Growing need for several blood components, increasing prevalence of accidents globally, and additional government initiatives toward blood donation are a few primary drivers accelerating the therapeutic apheresis market. |
|
Opportunity |
The growing demand for plasma-derived medicines production and well-established healthcare infrastructure and rising need for blood components across the globe is expected to increase the growth of the therapeutics apheresis market. |
Plasmapheresis Market :
|
Attributes |
Plasmapheresis Market |
|
Growth Factor |
Increasing prevalence of thrombotic thrombocytopenic purpura, Guillain-Barre syndrome, Myasthenia gravis, and diffuse alveolar hemorrhage due to Goodpasture syndrome, hyper viscosity syndrome, chronic inflammatory demyelinating polyneuropathy, and other autoimmune diseases is likely to drive the market growth. |
|
Opportunity |
Increasing adoption of plasmapheresis treatment in veterinary healthcare and regular advancements in technologies and reduction in costs is projected to drive the market |
Region-Wise Insights
What is the Growth Scenario of North America Apheresis Markets?
Technological advancement in healthcare to boost the market in North America
High technological prowess coupled with government aid supporting research & development activities is increasing the concentration of manufacturers in North America. Advancements in the healthcare sector and progressive improvements in the quality of services have been increasing patients’ reliance on hospitals and clinics.
Besides this, easy access to advanced apheresis products, on the backdrop of ongoing development initiatives undertaken by market players, further expands the patient pool in the region.
Considering these drivers, North America is expected to lead the growth of the apheresis market, with the regional market registering a CAGR of ~10% during the forecast period.
What is the Growth Prospect of the Asia Pacific Apheresis Market?
Increasing prevalence of the chronic disorder in the region to boost the market growth
Asia Pacific is expected to register the highest CAGR during the forecasting period due to the high population base and growing geriatric population in the region. The presence of high unmet needs and rapidly increasing demand for platelets in the region are expected to provide growth opportunities for the apheresis market during the forecast period.
The increasing cases of chronic diseases such as autoimmune diseases and cancer, the growing number of organ donors, and the increasing number of complicated surgical procedures also is supporting the growth of the market in this region.
East Asian countries such as Japan, and China, are some of the leading consumers of apheresis due to which they are holding more than 1/5th of market share in the regional market. The regular advancements in technologies and reduction in costs are likely to boost the Chinese apheresis market which will support to overall apheresis market during 2022 &2032.
Among other regions, manufacturers in the apheresis market in Japan are taking the technological approach to foster innovation in the development of apheresis products, which is anticipated to strengthen the Asia Pacific apheresis market.
Though reimbursement scenarios are likely to offer coverage in developing countries in future, it is imperative that market players adopt a cost-competitive strategy to achieve better penetration rate of products in these regions.
Category-wise Insights
Based on the procedure which segment holds the highest market value?
Plasmapheresis is expected to be the highest revenue-generating procedure type.
The plasmapheresis segment is the top procedure type segment which grew with a CAGR of 11.1% during 2017-2021 and is anticipated to bounce and grow with a CAGR of 10.7% in the forecasted period of 2022-2032.
This is partly because of the numerous applications of these procedures in plasma exchange in therapeutic processes. And increasing applications in renal and metabolic diseases, and hematologic and neurologic disorder.
Which is the more promising application type segment?
Neurology accounts for the highest share of the application segment
The neurology segment is expected to witness the fastest growth over the forecast period. According to the National MS Society. Nearly 1 million people are living with MS in the United States, This is more than twice the original estimate and means solutions for MS are now twice as important.
Moreover, the annual incidence of this disease in the U.S. alone amounted to 10,000. Procedural advantages such as lower blood loss and shorter treatment duration owing to complete automation are also expected to have a positive impact on growth.
Start-Ups for Apheresis Market
The new companies that have started to deal with the various kinds of apheresis procedures have been focused on employing smart technologies to enhance productivity as well as efficiency in the field. Some of the recent developments of apheresis market providers are as follows
- Bioelettronica is an equipment manufacturer which produces and sells devices for blood bank handling from collection to separation. New Biomixer BM330 from Bioelettronica has a unique programming capability which makes the blood centres free to choose their own strategy for data registration associated to blood collection and later easily change it according to new global or local regulations or after their own wishes. The device is ready to be connected to a local network for transferring registration and collection data to a central host.
Competitive Landscape
Some of the leading incumbent players and vendors working within the global apheresis market are Terumo Corporation, Fresenius Kabi AG, B. Braun Melsungen AG, NIKKISO Co., Ltd., Medica S. p. A., Asahi Kasei Medical Co. Ltd., Haemonetics Corporation, Cerus Corporation, Kawasumi Laboratories, Inc., and Therakos, Inc., among others.
Key manufacturers of apheresis are constantly innovating to meet new challenges that are evolving daily. Prominent market players are focusing on a competitive market pricing strategy, which includes the installation of integrated systems along with high-end software.
Apheresis companies are entering into collaborations and partnerships with governments and end-use industries for increasing the installation rate of apheresis systems.
- In January 2020 - Fresenius Kabi inaugurated the expansion of the transfusion and apheresis disposables plant in the Dominican Republic. The company manufactures apheresis sets. These products are used, for example, to collect blood components such as platelets or plasma. Fresenius Kabi undertook the expansion to meet the rising demand for these high-quality disposables used for critically important donations.
- In September 2020 - NIKKISO CO., LTD. participated in the in China Medical Equipment Fair (CMEF) & International Component Manufacturing Design Show (ICMD), a global exhibition for the medical devices market. It will take place in Shanghai during October 19th-22nd, 2020
- In August, 2022 - Haemonetics Corporation announced an agreement with Epic, a leading Electronic Health Record (EHR) system, to offer Haemonetics' SafeTrace Tx® blood bank information system to Epic's global network of hospitals.
Key Segments Covered in Apheresis Industry Survey
-
By Product :
- Devices
- Disposables
-
By Application :
- Renal Diseases
- Neurology
- Haematology
- Cancer
- Autoimmune Diseases
- Cardiovascular Diseases
- Others (Fibrosis and Diabetes)
-
By Procedure :
- Plasmapheresis
- Photopheresis
- LDL Apheresis
- Plateletpheresis
- Leukapheresis
- Erythrocytapheresis
- Others (Lymphapheresis and extracorporeal immunoadsorption)
-
By Technology :
- Centrifugation
- Membrane Filtration
-
By End User :
- Hospitals
- Blood Collection Centres
- Public
- Private
-
By Region :
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East &Africa
Table of Content
1. Preface 1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary 4. Market Definition 4.1. Introduction 4.1.1. Product/Service Definition 4.1.2. Industry Evolution / Developments 4.2. Market Overview 4.3. Key Market Indicators 4.3.1. Global Health Care Expenditure Scenario 4.4. Market Dynamics 4.4.1. Drivers 4.4.2. Restraints 4.4.3. Opportunities 4.5. Market (Therapeutic & Donor Apheresis) Analysis and Forecast, 2016 – 2024 4.5.1. Market Revenue Projections (US$ Mn) 4.6. Market (Therapeutic & Donor Apheresis) - Global Supply Demand Scenario 4.7. Porter’s Five Force Analysis 4.8. Event Impact Analysis 4.9. Market Outlook 5. Global Market (Therapeutic & Donor Apheresis) Analysis and Forecasts, By Product 5.1. Introduction & Definition 5.2. Key Findings / Developments 5.3. Key Trends 5.4. Market Size (US$ Mn) Forecast By Product 5.4.1. Devices 5.4.2. Disposables 5.5. Market Attractiveness By Product 6. Global Market (Therapeutic & Donor Apheresis) Analysis and Forecast, By Application 6.1. Introduction & Definition 6.2. Key Findings / Developments 6.3. Key Trends 6.4. Market Size (US$ Mn) Forecast, By Application 6.4.1. Renal diseases 6.4.2. Neurology 6.4.3. Hematology 6.4.4. Cancer 6.4.5. Autoimmune disease 6.4.6. Cardiovascular diseases 6.4.7. Others (e.g. Fibrosis, Diabetes, Dermatology etc.) 6.5. Comparison Matrix 6.6. Market Attractiveness By Application 7. Global Market (Therapeutic & Donor Apheresis) Analysis and Forecasts, By Procedure 7.1. Introduction & Definition 7.2. Key Findings / Developments 7.3. Key Trends 7.4. Market Size (US$ Mn) Forecast By Procedure 7.4.1. Plasmapheresis 7.4.2. Photopheresis 7.4.3. LDL-apheresis 7.4.4. Plateletpheresis 7.4.5. Leukapheresis 7.4.6. Erythrocytapheresis 7.4.7. Others (e.g. lymphapheresis, extracorporeal immunoadsorption, etc.) 7.5. Comparison Matrix 7.6. Market Attractiveness By Procedure 8. Global Market (Therapeutic & Donor Apheresis) Analysis and Forecasts, By Technology 8.1. Introduction & Definition 8.2. Key Findings / Developments 8.3. Key Trends 8.4. Market Size (US$ Mn) Forecast By Technology 8.4.1. Centrifugation 8.4.2. Membrane filtration 8.5. Comparison Matrix 8.6. Market Attractiveness By Technology 9. Global Market (Therapeutic & Donor Apheresis) Analysis and Forecasts, By End User 9.1. Introduction & Definition 9.2. Key Findings / Developments 9.3. Key Trends 9.4. Market Size (US$ Mn) Forecast By End User 9.4.1. Hospitals 9.4.2. Blood Collection Centers 9.4.2.1. Public 9.4.2.2. private 9.5. Comparison Matrix 9.6. Market Attractiveness By End User 10. Global Market (Therapeutic & Donor Apheresis) Analysis and Forecasts, By Region 10.1. Key Findings 10.2. Policies and Regulations 10.3. Market Size (US$ Mn) Forecast By Region 10.3.1. North America 10.3.2. Europe 10.3.3. Asia Pacific 10.3.4. Latin America 10.3.5. Middle East & Africa 10.4. Market Attractiveness By Country/Region 11. North America Market (Therapeutic & Donor Apheresis) Analysis and Forecast 11.1. Introduction & Definition 11.2. Key Findings / Developments 11.3. Key Trends 11.4. Market Size (US$ Mn) Forecast, By Country 11.4.1. U.S. 11.4.2. Canada 11.5. Market Size (US$ Mn) Forecast By Product 11.5.1. Devices 11.5.2. Disposables 11.6. Market Size (US$ Mn) Forecast, By Application 11.6.1. Renal diseases 11.6.2. Neurology 11.6.3. Hematology 11.6.4. Cancer 11.6.5. Autoimmune disease 11.6.6. Cardiovascular diseases 11.6.7. Others 11.7. Market Size (US$ Mn) Forecast By Procedure 11.7.1. Plasmapheresis 11.7.2. Photopheresis 11.7.3. LDL-apheresis 11.7.4. Plateletpheresis 11.7.5. Leukapheresis 11.7.6. Erythrocytapheresis 11.7.7. Others 11.8. Market Size (US$ Mn) Forecast, By Technology 11.8.1. Centrifugation 11.8.2. Membrane filtration 11.9. Market Size (US$ Mn) Forecast, By End User 11.9.1. Hospitals 11.9.2. Blood Collection Centers 11.9.2.1. Public 11.9.2.2. private 11.10. Market Attractiveness Analysis 11.10.1. By Country 11.10.2. By Product 11.10.3. By Application 11.10.4. By Procedure 11.10.5. By Technology 11.10.6. By End User 12. Europe Market (Therapeutic & Donor Apheresis) Analysis and Forecast 12.1. Introduction & Definition 12.2. Key Findings / Developments 12.3. Key Trends 12.4. Market Size (US$ Mn) Forecast, By Country 12.4.1. Germany 12.4.2. France 12.4.3. U.K. 12.4.4. Italy 12.4.5. Spain 12.4.6. Rest of Europe 12.5. Market Size (US$ Mn) Forecast By Product 12.5.1. Devices 12.5.2. Disposables 12.6. Market Size (US$ Mn) Forecast, By Application 12.6.1. Renal diseases 12.6.2. Neurology 12.6.3. Hematology 12.6.4. Cancer 12.6.5. Autoimmune disease 12.6.6. Cardiovascular diseases 12.6.7. Others 12.7. Market Size (US$ Mn) Forecast By Procedure 12.7.1. Plasmapheresis 12.7.2. Photopheresis 12.7.3. LDL apheresis 12.7.4. Plateletpheresis 12.7.5. Leukapheresis 12.7.6. Erythrocytapheresis 12.7.7. Others 12.8. Market Size (US$ Mn) Forecast, By Technology 12.8.1. Centrifugation 12.8.2. Membrane filtration 12.9. Market Size (US$ Mn) Forecast, By End User 12.9.1. Hospitals 12.9.2. Blood Collection Centers 12.9.2.1. Public 12.9.2.2. private 12.10. Market Attractiveness Analysis 12.10.1. By Country 12.10.2. By Product 12.10.3. By Application 12.10.4. By Procedure 12.10.5. By Technology 12.10.6. By End User 13. Asia Pacific Market (Therapeutic & Donor Apheresis) Analysis and Forecast 13.1. Introduction & Definition 13.2. Key Findings / Developments 13.3. Key Trends 13.4. Market Size (US$ Mn) Forecast, By Country 13.4.1. Japan 13.4.2. China 13.4.3. India 13.4.4. Australia 13.4.5. Rest of Asia Pacific 13.5. Market Size (US$ Mn) Forecast By Product 13.5.1. Devices 13.5.2. Disposables 13.6. Market Size (US$ Mn) Forecast, By Application 13.6.1. Renal diseases 13.6.2. Neurology 13.6.3. Hematology 13.6.4. Cancer 13.6.5. Autoimmune disease 13.6.6. Cardiovascular diseases 13.6.7. Others 13.7. Market Size (US$ Mn) Forecast By Procedure 13.7.1. Plasmapheresis 13.7.2. Photopheresis 13.7.3. LDL-apheresis 13.7.4. Plateletpheresis 13.7.5. Leukapheresis 13.7.6. Erythrocytapheresis 13.7.7. Others 13.8. Market Size (US$ Mn) Forecast, By Technology 13.8.1. Centrifugation 13.8.2. Membrane filtration 13.9. Market Size (US$ Mn) Forecast, By End User 13.9.1. Hospitals 13.9.2. Blood Collection Centers 13.9.2.1. Public 13.9.2.2. private 13.10. Market Attractiveness Analysis 13.10.1. By Country 13.10.2. By Product 13.10.3. By Application 13.10.4. By Procedure 13.10.5. By Technology 13.10.6. By End User 14. Latin America Market (Therapeutic & Donor Apheresis) Analysis and Forecast 14.1. Introduction & Definition 14.2. Key Findings / Developments 14.3. Key Trends 14.4. Market Size (US$ Mn) Forecast, By Country 14.4.1. Brazil 14.4.2. Mexico 14.4.3. Rest of Latin America 14.5. Market Size (US$ Mn) Forecast By Product 14.5.1. Devices 14.5.2. Disposables 14.6. Market Size (US$ Mn) Forecast, By Application 14.6.1. Renal diseases 14.6.2. Neurology 14.6.3. Hematology 14.6.4. Cancer 14.6.5. Autoimmune disease 14.6.6. Cardiovascular diseases 14.6.7. Others 14.7. Market Size (US$ Mn) Forecast By Procedure 14.7.1. Plasmapheresis 14.7.2. Photopheresis 14.7.3. LDL-apheresis 14.7.4. Plateletpheresis 14.7.5. Leukapheresis 14.7.6. Erythrocytapheresis 14.7.7. Others 14.8. Market Size (US$ Mn) Forecast, By Technology 14.8.1. Centrifugation 14.8.2. Membrane filtration 14.9. Market Size (US$ Mn) Forecast, By End User 14.9.1. Hospitals 14.9.2. Blood Collection Centers 14.9.2.1. Public 14.9.2.2. private 14.10. Market Attractiveness Analysis 14.10.1. By Country 14.10.2. By Product 14.10.3. By Application 14.10.4. By Procedure 14.10.5. By Technology 14.10.6. By End User 15. Middle East & Africa Market (Therapeutic & Donor Apheresis) Analysis and Forecast 15.1. Introduction & Definition 15.2. Key Findings / Developments 15.3. Key Trends 15.4. Market Size (US$ Mn) Forecast, By Country 15.4.1. Saudi Arabia 15.4.2. South Africa 15.4.3. Rest of MEA 15.5. Market Size (US$ Mn) Forecast By Product 15.5.1. Devices 15.5.2. Disposables 15.6. Market Size (US$ Mn) Forecast, By Application 15.6.1. Renal diseases 15.6.2. Neurology 15.6.3. Hematology 15.6.4. Cancer 15.6.5. Autoimmune disease 15.6.6. Cardiovascular diseases 15.6.7. Others 15.7. Market Size (US$ Mn) Forecast By Procedure 15.7.1. Plasmapheresis 15.7.2. Photopheresis 15.7.3. LDL-apheresis 15.7.4. Plateletpheresis 15.7.5. Leukapheresis 15.7.6. Erythrocytapheresis 15.7.7. Others 15.8. Market Size (US$ Mn) Forecast, By Technology 15.8.1. Centrifugation 15.8.2. Membrane filtration 15.9. Market Size (US$ Mn) Forecast, By End User 15.9.1. Hospitals 15.9.2. Blood Collection Centers 15.9.2.1. Public 15.9.2.2. private 15.10. Market Attractiveness Analysis 15.10.1. By Country 15.10.2. By Product 15.10.3. By Application 15.10.4. By Procedure 15.10.5. By Technology 15.10.6. By End User 16. Competition Landscape 16.1. Market Player – Competition Matrix (By Tier and Size of companies) 16.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy) 16.2.1. Asahi Kasei Medical Co., Ltd. 16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength) 16.2.1.2. Product Portfolio 16.2.1.3. SWOT Analysis 16.2.1.4. Financial Overview 16.2.1.5. Strategic Overview 16.2.2. B. Braun Melsungen AG 16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength) 16.2.2.2. Product Portfolio 16.2.2.3. SWOT Analysis 16.2.2.4. Financial Overview 16.2.2.5. Strategic Overview 16.2.3. Cerus Corporation 16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength) 16.2.3.2. Product Portfolio 16.2.3.3. SWOT Analysis 16.2.3.4. Financial Overview 16.2.3.5. Strategic Overview 16.2.4. Fresenius Medical Care 16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength) 16.2.4.2. Product Portfolio 16.2.4.3. SWOT Analysis 16.2.4.4. Financial Overview 16.2.4.5. Strategic Overview 16.2.5. Haemonetics Corp. 16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength) 16.2.5.2. Product Portfolio 16.2.5.3. SWOT Analysis 16.2.5.4. Financial Overview 16.2.5.5. Strategic Overview 16.2.6. Hemacare Corporation 16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength) 16.2.6.2. Product Portfolio 16.2.6.3. SWOT Analysis 16.2.6.4. Financial Overview 16.2.6.5. Strategic Overview 16.2.7. Kawasumi Laboratories Inc. 16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength) 16.2.7.2. Product Portfolio 16.2.7.3. SWOT Analysis 16.2.7.4. Financial Overview 16.2.7.5. Strategic Overview 16.2.8. Medica S.p.A. 16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength) 16.2.8.2. Product Portfolio 16.2.8.3. SWOT Analysis 16.2.8.4. Financial Overview 16.2.8.5. Strategic Overview 16.2.9. NIKKISO CO., LTD. 16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength) 16.2.9.2. Product Portfolio 16.2.9.3. SWOT Analysis 16.2.9.4. Financial Overview 16.2.9.5. Strategic Overview 16.2.10. Terumo Corporation 16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength) 16.2.10.2. Product Portfolio 16.2.10.3. SWOT Analysis 16.2.10.4. Financial Overview 16.2.10.5. Strategic Overview 16.2.11. Therakos, Inc. 16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength) 16.2.11.2. Product Portfolio 16.2.11.3. SWOT Analysis 16.2.11.4. Financial Overview 16.2.11.5. Strategic Overview
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Forecast, by Product, 2022-2032
Table 02: Global Market Value (US$ Mn) Forecast, by Application, 2022-2032
Table 03: Global Market Value (US$ Mn) Forecast, by Procedure, 2022-2032
Table 04: Global Market Value (US$ Mn) Forecast, by Technology, 2022-2032
Table 05: Global Market Value (US$ Mn) Forecast, by End User, 2022-2032
Table 06: Global Market Value (US$ Mn) Forecast, by End User (blood collection center), 2022-2032
Table 07: Global Market Size (US$ Mn) Forecast, by Region, 2022-2032
Table 08: North America Market Value (US$ Mn) Forecast, by Product, 2022-2032
Table 09: North America Market Value (US$ Mn) Forecast, by Application, 2022-2032
Table 10: North America Market Value (US$ Mn) Forecast, by Procedure, 2022-2032
Table 11: North America Market Value (US$ Mn) Forecast, by Technology, 2022-2032
Table 12: North America Market Value (US$ Mn) Forecast, by End User, 2022-2032
Table 13: North America Market Value (US$ Mn) Forecast, by End User (blood collection center), 2022-2032
Table 14: North America Market Value (US$ Mn) Forecast, by Country, 2022-2032
Table 15: Europe Market Value (US$ Mn) Forecast, by Product, 2022-2032
Table 16: Europe Market Value (US$ Mn) Forecast, by Application, 2022-2032
Table 17: Europe Market Value (US$ Mn) Forecast, by Procedure, 2022-2032
Table 18: Europe Market Value (US$ Mn) Forecast, by Technology, 2022-2032
Table 19: Europe Market Value (US$ Mn) Forecast, by End User, 2022-2032
Table 20: Europe Market Value (US$ Mn) Forecast, by End User (Blood Collection Centers), 2022-2032
Table 21: Europe Market Value (US$ Mn) Forecast, by Country / Sub-region, 2022-2032
Table 22: Asia Pacific Market Value (US$ Mn) Forecast, by Product, 2022-2032
Table 23: Asia Pacific Market Value (US$ Mn) Forecast, by Application, 2022-2032
Table 24: Asia Pacific Market Value (US$ Mn) Forecast, by Procedure, 2022-2032
Table 25: Asia Pacific Market Value (US$ Mn) Forecast, by Technology, 2022-2032
Table 26: Asia Pacific Market Value (US$ Mn) Forecast, by End User, 2022-2032
Table 27: Asia Pacific Market Value (US$ Mn) Forecast, by End User (Blood Collection Centers), 2022-2032
Table 28: Asia Pacific Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022-2032
Table 29: Latin America Market Value (US$ Mn) Forecast, by Product, 2022-2032
Table 30: Latin America Market Value (US$ Mn) Forecast, by Application, 2022-2032
Table 31: Latin America Market Value (US$ Mn) Forecast, by Procedure, 2022-2032
Table 32: Latin America Market Value (US$ Mn) Forecast, by Technology, 2022-2032
Table 33: Latin America Market Value (US$ Mn) Forecast, by End User, 2022-2032
Table 34: Latin America Market Value (US$ Mn) Forecast, by End User (Blood Collection Centers), 2022-2032
Table 35: Latin America Market Value (US$ Mn) Forecast, by Country / Sub-region, 2022-2032
Table 36: Middle East & Africa Market Value (US$ Mn) Forecast, by Product, 2022-2032
Table 37: Middle East & Africa Market Value (US$ Mn) Forecast, by Application, 2022-2032
Table 38: Middle East & Africa Market Value (US$ Mn) Forecast, by Procedure, 2022-2032
Table 39: Middle East & Africa Market Value (US$ Mn) Forecast, by Technology, 2022-2032
Table 40: Middle East & Africa Market Value (US$ Mn) Forecast, by End User, 2022-2032
Table 41: Middle East & Africa Market Value (US$ Mn) Forecast, by End User (blood collection center), 2022-2032
Table 42: Middle East & Africa Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022-2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2032
Figure 02: Global Market Value Share Analysis, by Product, 2017 and 2032
Figure 03: Global Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2022-2032
Figure 04: Global Disposables Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2022-2032
Figure 05: Global Market Attractiveness Analysis, by Product
Figure 06: Global Market Value Share Analysis, by Application, 2017 and 2032
Figure 07: Global in Renal Diseases Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2022-2032
Figure 08: Global in Neurology Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2022-2032
Figure 09: Global in Hematology Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2022-2032
Figure 10: Global in Cancer Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2022-2032
Figure 11: Global in Autoimmune Diseases Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2022-2032
Figure 12: Global in Cardiovascular Diseases Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2022-2032
Figure 13: Global in Other Applications Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2022-2032
Figure 14: Global Market Attractiveness Analysis, by Application
Figure 15: Global Market Value Share Analysis, by Procedure, 2017 and 2032
Figure 16: Global Plasmapheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2022-2032
Figure 17: Global Photopheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2022-2032
Figure 18: Global LDL-Apheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2022-2032
Figure 19: Global Plateletpheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2022-2032
Figure 20: Global Leukapheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2022-2032
Figure 21: Global Erythrocytapheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2022-2032
Figure 22: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other Procedures, 2022-2032
Figure 23: Global Market Attractiveness Analysis, by Procedure
Figure 24: Global Market Value Share Analysis, by Technology, 2017 and 2032
Figure 25: Global Centrifugation Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2022-2032
Figure 26: Global Membrane Filtration Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2022-2032
Figure 27: Global Market Attractiveness Analysis, by Technology
Figure 28: Global Market Value Share Analysis, by End User, 2017 and 2032
Figure 29: Global Market Value Share Analysis, by End User (blood collection centers), 2017 and 2032
Figure 30: Global Hospitals Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2022-2032
Figure 31: Global Blood Collection Centres Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2022-2032
Figure 32: Global Private Blood Collection Centres Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2022-2032
Figure 33: Global Public Blood Collection Centres Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2022-2032
Figure 34: Global Market Attractiveness Analysis, by End User
Figure 35: Global Market Value Share Analysis, by Region, 2017 and 2032
Figure 36: Global Market Attractiveness Analysis, by Region
Figure 37: North America Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2032
Figure 38: North America Market Attractiveness Analysis, by Country
Figure 39: North America Market Value Share Analysis, by Product, 2017 and 2032
Figure 40: North America Market Value Share Analysis, by Application, 2017 and 2032
Figure 41: North America Market Value Share Analysis, by Procedure, 2017 and 2032
Figure 42: North America Market Value Share Analysis, by Technology, 2017 and 2032
Figure 43: North America Market Value Share Analysis, by End User, 2017 and 2032
Figure 44: North America Market Value Share Analysis, by End User (blood collection center), 2017 and 2032
Figure 45: North America Market Value Share Analysis, by Country, 2017 and 2032
Figure 46: North America Market Attractiveness Analysis, by Product
Figure 47: North America Market Attractiveness Analysis, by Application
Figure 48: North America Market Attractiveness Analysis, by Procedure
Figure 49: North America Market Attractiveness Analysis, by Technology
Figure 50: North America Market Attractiveness Analysis, by End User
Figure 51: Europe Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection, 2017-2032
Figure 52: Europe Market Attractiveness Analysis, by Country / Sub-region
Figure 53: Europe Market Value Share Analysis, by Product, 2017 and 2032
Figure 54: Europe Market Value Share Analysis, by Application, 2017 and 2032
Figure 55: Europe Market Value Share Analysis, by Procedure, 2017 and 2032
Figure 56: Europe Market Value Share Analysis, by Technology, 2017 and 2032
Figure 57: Europe Market Value Share Analysis, by End User, 2017 and 2032
Figure 58: Europe Market Value Share Analysis, by End User (Blood Collection Centers), 2017 and 2032
Figure 59: Europe Market Value Share Analysis, by Country / Sub-region, 2017 and 2032
Figure 60: Europe Market Attractiveness Analysis, by Product
Figure 61: Europe Market Attractiveness Analysis, by Application
Figure 62: Europe Market Attractiveness Analysis, by Procedure
Figure 63: Europe Market Attractiveness Analysis, by Technology
Figure 64: Europe Market Attractiveness Analysis, by End User
Figure 65: Asia Pacific Market Size (US$ Mn) Forecast, 2017-2032
Figure 66: Asia Pacific Market Attractiveness Analysis, by Country
Figure 67: Asia Pacific Market Value Share Analysis, by Product, 2017 and 2032
Figure 68: Asia Pacific Market Value Share Analysis, by Application, 2017 and 2032
Figure 69: Asia Pacific Market Value Share Analysis, by Procedure, 2017 and 2032
Figure 70: Asia Pacific Market Value Share Analysis, by Technology, 2017 and 2032
Figure 71: Asia Pacific Market Value Share Analysis, by End User, 2017 and 2032
Figure 72: Asia Pacific Market Value Share Analysis, by End User (Blood Collection Centers), 2017 and 2032
Figure 73: Asia Pacific Market Value Share Analysis, by Country/Sub-region, 2017 and 2032
Figure 74: Asia Pacific Market Attractiveness Analysis, by Product
Figure 75: Asia Pacific Market Attractiveness Analysis, by Application
Figure 76: Asia Pacific Market Attractiveness Analysis, by Procedure
Figure 77: Asia Pacific Market Attractiveness Analysis, by Technology
Figure 78: Asia Pacific Market Attractiveness Analysis, by End User
Figure 79: Latin America Market Size (US$ Mn) Forecast, 2017-2032
Figure 80: Latin America Market Attractiveness Analysis, by Country / Sub-region
Figure 81: Latin America Market Value Share Analysis, by Product, 2017 and 2032
Figure 82: Latin America Market Value Share Analysis, by Application, 2017 and 2032
Figure 83: Latin America Market Value Share Analysis, by Procedure, 2017 and 2032
Figure 84: Latin America Market Value Share Analysis, by Technology, 2017 and 2032
Figure 85: Latin America Market Value Share Analysis, by End User, 2017 and 2032
Figure 86: Latin America Market Value Share Analysis, by End User (Blood Collection Centers), 2017 and 2032
Figure 87: Latin America Market Value Share Analysis, by Country / Sub-region, 2017 and 2032
Figure 88: Latin America Market Attractiveness Analysis, by Product
Figure 89: Latin America Market Attractiveness Analysis, by Application
Figure 90: Latin America Market Attractiveness Analysis, by Procedure
Figure 91: Latin America Market Attractiveness Analysis, by Technology
Figure 92: Latin America Market Attractiveness Analysis, by End User
Figure 93: Middle East & Africa Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2032
Figure 94: Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region
Figure 95: Middle East & Africa Market Value Share Analysis, by Product, 2017 and 2032
Figure 96: Middle East & Africa Market Value Share Analysis, by Application, 2017 and 2032
Figure 97: Middle East & Africa Market Value Share Analysis, by Procedure, 2017 and 2032
Figure 98: Middle East & Africa Market Value Share Analysis, by Technology, 2017 and 2032
Figure 99: Middle East & Africa Market Value Share Analysis, by End User, 2017 and 2032
Figure 100: Middle East & Africa Market Value Share Analysis, by End User (blood collection center), 2017 and 2032
Figure 101: Middle East & Africa Market Value Share Analysis, by Country/Sub-region, 2017 and 2032
Figure 102: Middle East & Africa Market Attractiveness Analysis, by Product
Figure 103: Middle East & Africa Market Attractiveness Analysis, by Application
Figure 104: Middle East & Africa Market Attractiveness Analysis, by Procedure
Figure 105: Middle East & Africa Market Attractiveness Analysis, by Technology
Figure 106: Middle East & Africa Market Attractiveness Analysis, by End User
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How much is the current worth of the apheresis market?
The apheresis market is worth US$ 2990 Billion at present.
What is the growth forecast for the apheresis market?
The value of the apheresis market is projected to increase at a CAGR of around 11.6% during 2022 – 2032.
What are the segments covered in the apheresis market?
The report has segmented the landscape on the basis of end-user, technology, procedure, application, product, and region.
Which segment has a better grip over the market in terms of procedure type?
Plasmapheresis has better stats over the market in 2021 and is expected to grow at a CAGR of 10.6% in the next 10 years.
At what rate is Neurology, an application segment, is expected to grow between 2022-2032?
The neurology segment is expected to grow with a CAGR of 10.9% during the forecasted period of 2022-2032.
Apheresis Market